On ECHEMI
Home > Drugs > Meniere's disease
Meniere's disease
Meniere's syndrome is an inner ear disease characterized by hydrops in the labyrinth. The main clinical manifestations of this disease are sudden vertigo, tinnitus, deafness or nystagmus. Vertigo has obvious attack and intermittent periods. Most patients are middle-aged, with no significant difference in gender. About 65% of patients have their first attack before the age of 50, and most patients have the disease in one ear.
  • Site of disease:

    Ear
  • Infectious :

    Not contagious
  • Frequent population:

    Young and middle-aged people aged 30 to 50
  • Related symptoms:

    Dysphagia Hearing loss Nausea Tinnitus Vertigo
  • Concurrent disease:

Related Drugs
Betahistine mesylate
Indication: Dizziness and lightheadedness associated with the following diseases: Meniere's disease, Meniere's syndrome, vertigo.
Betahistine mesylate
Indication: Dizziness and lightheadedness associated with the following diseases: Meniere's disease, Meniere's syndrome, vertigo.
Manufacturer:

Guangdong Shixin Pharmaceutical Co., Ltd.

Betahistine mesylate
Indication: Dizziness and lightheadedness associated with the following diseases: Meniere's disease, Meniere's syndrome, vertigo.
Manufacturer:

Guangdong Shixin Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.